Product Code: ETC10162254 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Atherosclerotic Cardiovascular Disease Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, 2021 & 2031F |
3.3 India Atherosclerotic Cardiovascular Disease Market - Industry Life Cycle |
3.4 India Atherosclerotic Cardiovascular Disease Market - Porter's Five Forces |
3.5 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.6 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Therapeutic Approach, 2021 & 2031F |
3.8 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Risk Factors, 2021 & 2031F |
4 India Atherosclerotic Cardiovascular Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as diabetes, hypertension, and obesity in India |
4.2.2 Growing awareness about cardiovascular diseases and preventive measures |
4.2.3 Advancements in medical technology leading to improved diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost of cardiovascular disease treatments |
4.3.3 Lack of skilled healthcare professionals specialized in cardiovascular care |
5 India Atherosclerotic Cardiovascular Disease Market Trends |
6 India Atherosclerotic Cardiovascular Disease Market, By Types |
6.1 India Atherosclerotic Cardiovascular Disease Market, By Disease Area |
6.1.1 Overview and Analysis |
6.1.2 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Disease Area, 2021 - 2031F |
6.1.3 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Atherosclerosis, 2021 - 2031F |
6.1.4 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Coronary Artery Disease, 2021 - 2031F |
6.1.5 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Heart Attack, 2021 - 2031F |
6.2 India Atherosclerotic Cardiovascular Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Medical Therapy, 2021 - 2031F |
6.2.3 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Surgical Therapy, 2021 - 2031F |
6.2.4 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Preventive Medicine, 2021 - 2031F |
6.3 India Atherosclerotic Cardiovascular Disease Market, By Therapeutic Approach |
6.3.1 Overview and Analysis |
6.3.2 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Statins, 2021 - 2031F |
6.3.3 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Angioplasty, 2021 - 2031F |
6.3.4 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Beta-blockers, 2021 - 2031F |
6.4 India Atherosclerotic Cardiovascular Disease Market, By Risk Factors |
6.4.1 Overview and Analysis |
6.4.2 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Obesity, 2021 - 2031F |
6.4.3 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Hypertension, 2021 - 2031F |
6.4.4 India Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Diabetes, 2021 - 2031F |
7 India Atherosclerotic Cardiovascular Disease Market Import-Export Trade Statistics |
7.1 India Atherosclerotic Cardiovascular Disease Market Export to Major Countries |
7.2 India Atherosclerotic Cardiovascular Disease Market Imports from Major Countries |
8 India Atherosclerotic Cardiovascular Disease Market Key Performance Indicators |
8.1 Percentage increase in adoption of healthy lifestyle practices in the population |
8.2 Number of new cardiovascular disease cases diagnosed annually |
8.3 Rate of utilization of cardiovascular disease screening programs |
8.4 Percentage of patients receiving timely and appropriate treatment |
8.5 Level of government investment in healthcare infrastructure and programs targeting cardiovascular diseases |
9 India Atherosclerotic Cardiovascular Disease Market - Opportunity Assessment |
9.1 India Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.2 India Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Therapeutic Approach, 2021 & 2031F |
9.4 India Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Risk Factors, 2021 & 2031F |
10 India Atherosclerotic Cardiovascular Disease Market - Competitive Landscape |
10.1 India Atherosclerotic Cardiovascular Disease Market Revenue Share, By Companies, 2024 |
10.2 India Atherosclerotic Cardiovascular Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |